These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 36517799)

  • 1. The prebiotic effects of soluble dietary fiber mixture on renal anemia and the gut microbiota in end-stage renal disease patients on maintenance hemodialysis: a prospective, randomized, placebo-controlled study.
    Li Y; Han M; Song J; Liu S; Wang Y; Su X; Wei K; Xu Z; Li H; Wang Z
    J Transl Med; 2022 Dec; 20(1):599. PubMed ID: 36517799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifactorial analysis of renal anemia-associated substandard hemoglobin levels and prevalence of anemia in patients on maintenance hemodialysis in Liaoning Province: a cross-sectional study.
    Yin S; Du Y; Guo Y; Guo G; Sun D; Yao L
    Ann Palliat Med; 2022 Dec; 11(12):3743-3754. PubMed ID: 36635999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum soluble transferrin receptor reflects erythropoiesis but not iron availability in erythropoietin-treated chronic hemodialysis patients.
    Chiang WC; Tsai TJ; Chen YM; Lin SL; Hsieh BS
    Clin Nephrol; 2002 Nov; 58(5):363-9. PubMed ID: 12425487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
    Li H; Wang SX
    Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut Microbiota Correlates With Clinical Responsiveness to Erythropoietin in Hemodialysis Patients With Anemia.
    Zhu Y; Tang Y; He H; Hu P; Sun W; Jin M; Wang L; Xu X
    Front Cell Infect Microbiol; 2022; 12():919352. PubMed ID: 35937691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inulin-type prebiotics reduce serum uric acid levels via gut microbiota modulation: a randomized, controlled crossover trial in peritoneal dialysis patients.
    He S; Xiong Q; Tian C; Li L; Zhao J; Lin X; Guo X; He Y; Liang W; Zuo X; Ying C
    Eur J Nutr; 2022 Mar; 61(2):665-677. PubMed ID: 34491388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anemia in hemodialysis patients: variables affecting this outcome predictor.
    Madore F; Lowrie EG; Brugnara C; Lew NL; Lazarus JM; Bridges K; Owen WF
    J Am Soc Nephrol; 1997 Dec; 8(12):1921-9. PubMed ID: 9402095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble transferrin receptor as a marker of erythropoiesis in patients undergoing high-flux hemodialysis.
    Yin P; Song Y; Li J
    Bosn J Basic Med Sci; 2017 Nov; 17(4):333-338. PubMed ID: 28446125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced fecal short-chain fatty acids levels and the relationship with gut microbiota in IgA nephropathy.
    Chai L; Luo Q; Cai K; Wang K; Xu B
    BMC Nephrol; 2021 Jun; 22(1):209. PubMed ID: 34082732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Dietary Fibers on Short-Chain Fatty Acids and Gut Microbiota Composition in Healthy Adults: A Systematic Review.
    Vinelli V; Biscotti P; Martini D; Del Bo' C; Marino M; Meroño T; Nikoloudaki O; Calabrese FM; Turroni S; Taverniti V; Unión Caballero A; Andrés-Lacueva C; Porrini M; Gobbetti M; De Angelis M; Brigidi P; Pinart M; Nimptsch K; Guglielmetti S; Riso P
    Nutrients; 2022 Jun; 14(13):. PubMed ID: 35807739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Assessment of iron requirements during treatment of anemia with recombinant human erythropoietin in patients with chronic renal insufficiency under hemodialysis].
    Oliveira C; Boquinhas H; Gaspar A; Adragão T; Boquinhas JM; Júnior EC; Simões J
    Acta Med Port; 1992 Jul; 5(7):351-7. PubMed ID: 1442178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human erythropoietin independence in chronic hemodialysis patients: clinical features, iron homeostasis and erythropoiesis.
    Kuo CC; Lee CT; Chuang CH; Su Y; Chen JB
    Clin Nephrol; 2005 Feb; 63(2):92-7. PubMed ID: 15730050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
    Nakamoto H; Mimura T; Honda N
    Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of frequency of intravenous iron administration on hemoglobin variability in maintenance hemodialysis patients.
    Wan L; Zhang D
    Int Urol Nephrol; 2018 Aug; 50(8):1511-1518. PubMed ID: 29946818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of epoetin therapy with intravenous iron therapy in hemodialysis patients.
    Besarab A; Amin N; Ahsan M; Vogel SE; Zazuwa G; Frinak S; Zazra JJ; Anandan JV; Gupta A
    J Am Soc Nephrol; 2000 Mar; 11(3):530-538. PubMed ID: 10703677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Defatted Rice Bran-Fortified Bread on the Gut Microbiota Composition of Healthy Adults With Low Dietary Fiber Intake: Protocol for a Crossover Randomized Controlled Trial.
    Ng HM; Maggo J; Wall CL; Bayer SB; McNabb WC; Mullaney JA; Foster M; Cabrera DL; Fraser K; Cooney J; Trower T; Günther CS; Frampton C; Gearry RB; Roy NC
    JMIR Res Protoc; 2024 Aug; 13():e59227. PubMed ID: 39207833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Intravenous Iron Supplementation on Hematinic Parameters and Erythropoietin Requirements in Hemodialysis Patients.
    Zununi Vahed S; Ahmadian E; Hejazian SM; Esmaeili S; Farnood F
    Adv Ther; 2021 Aug; 38(8):4413-4424. PubMed ID: 34254256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in gut microbiota in predigested Hibiscus sabdariffa L calyces and Agave (Agave tequilana weber) fructans assessed in a dynamic in vitro model (TIM-2) of the human colon.
    Sáyago-Ayerdi SG; Zamora-Gasga VM; Venema K
    Food Res Int; 2020 Jun; 132():109036. PubMed ID: 32331660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Opatija study: observation of hemodialysis patients and titration of CERA dose just switched from another erythropoiesis stimulating agent].
    Jelić I; Lovcić V; Kurtović I; Josipović M; Havranek Z; Kostić L; Racki S
    Acta Med Croatica; 2012 Jul; 66(3):157-64. PubMed ID: 23441529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved anemia and reduced erythropoietin need by medical or surgical intervention of secondary hyperparathyroidism in hemodialysis patients.
    Lin CL; Hung CC; Yang CT; Huang CC
    Ren Fail; 2004 May; 26(3):289-95. PubMed ID: 15354979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.